An interventional study of Bone expansion and implant placement with crest split and Bone expansion and implant placement with specifically design drills in Horizontal Alveolar Bone Loss, Implant Therapy and Primary Stability of the Implants, sponsored by Ege University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-02.
Sponsored by Ege University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 33 studies in Alveolar Bone Loss with a site in Turkey — 8 open to participants now, 10 under way, none of them phase 3. Alveolar Bone Loss · Turkey.
Among the 33 studies in Alveolar Bone Loss with a site in Turkey, this one is the 14th largest by enrollment of the 20 interventional ones that give a count, is one of 6 that started in 2023, is one of 18 with no phase, and was the 31st registered.
320 studies on the registry are indexed under Alveolar Bone Loss; 79 are open to participants now.
Browse Alveolar Bone Loss studies →8 of the 33 studies in Alveolar Bone Loss with a site in Turkey are open now. Recruiting first, the newest first:
Recep Tayyip Erdogan University Training and Research Hospital · Sites in Turkey
Ages 18–65 · Healthy volunteers
Saglik Bilimleri Universitesi · Sites in Turkey
Ages 18–65 · Healthy volunteers
Saglik Bilimleri Universitesi · Sites in Turkey
Ages 18–65 · Healthy volunteers
Kutahya Health Sciences University · Sites in Turkey
Ages 18–99 · Healthy volunteers
Istanbul Saglik Bilimleri University · Sites in Turkey
Ages 18–65 · Healthy volunteers
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 47 Alveolar Bone Loss studies recruiting now, 19 (40%) set no upper age limit and 22 (47%) stop at 75 or younger; 4 take children under 18; 24 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
33 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 6 started in 2023.
This study's enrollment of 20 is below the median of 25 across 271 interventional studies indexed under Alveolar Bone Loss.
Median enrollment 30 across the 20 interventional studies, 41 across the 13 observational. Of the 22 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 33 has an industry lead sponsor. The 10 most frequent:
Ege University is the lead sponsor of 377 studies on the registry; 48 are open to participants now.
Ege University has 4 studies filed under Alveolar Bone Loss — fewer than ten, so there is no comparison to draw.
2 of the studies in Alveolar Bone Loss with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07146776Saglik Bilimleri UniversitesiTreatment of Intrabony Defects With Injectable Platelet-Rich Fibrin and Xenogenic Grafts | 2026-12-01 |
| NCT07907900Ankara UniversityDiagnostic Accuracy of Large Language Models for Peri-Implant Marginal Bone Loss on Panoramic Radiographs | 2026-12-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 33 studies in Alveolar Bone Loss with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This was a prospective, randomized clinical trial conducted at the Department of Oral and Maxillofacial Surgery, Ege University. Patients exhibiting horizontal bone insufficiency (residual crest width \< 4 mm) in the posterior mandible received dental implants with two techniques: osseodensification or crest split. The investigator compared to clinical and radiological outcomes of these techniques.
This prospective, parallel-group randomized clinical trial was conducted at the Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Ege University, İzmir, Turkey, between February 2021 and August 2023.Patients exhibiting horizontal bone insufficiency (residual crest width \< 4 mm) in the posterior mandible received dental implants with two techniques. The primary predictor variable was the ridge expansion technique: Osseodensification (Group 1, n=10 patients, 21 implants) or Crest Split (Group 2, n=10 patients, 25 implants). primary outcome variables were primary stability. The secondary outcome variables were clinical bone expansion, intraoperative/postoperative complications, marginal bone level, plaque accumulation, and bleeding on probing.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Bone expansion and implant placement with crest split
Procedure: Bone expansion and implant placement with crest split
Bone expansion and implant placement with specifically design drills
Procedure: Bone expansion and implant placement with specifically design drills
Bone expansion was provided with chisel and mullet. Implant was inserted following expansion.
Bone expansion was provided with implant drills. Implant was inserted following expansion.
Mean of implant stability quantity (ISQ) value
Calculation of ISQ value: Measurement for each implant using resonance frequency analysis (RFA)
Time frame: At surgery
Mean of torque value
Calculation of torque value: Measurement for each implant using a ratchet and torque wrench
Time frame: At surgery
Marginal bone level
Change in peri-implant bone level
Time frame: through study completion, ana average of 2 year
Complication
Number of operative and postoperative complications
Time frame: through study completion, an average of 2 year
Peri-implant health
Calculation of bleeding on probing and plaque accumulation. Bleeding on probing: Assessment of bleeding presence/absence using a periodontal probe. Plaque accumulation: Assessment of plaque presence/absence using a modified plaque index.
Time frame: at 12 months
Plan to share: No
No publications or documents are linked to this record.
Ran from Dec 2023 to primary completion in Jun 2024, 6 months.
Of 169 non-industry interventional studies with no phase under Alveolar Bone Loss, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 30. This study's 6 months is below that.
Counting every sponsor, half of 169 studies reached it within 18 months; a quarter within 11 and three quarters within 30.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.